Home › Funds › Winthrop Partners - WNY, LLC › JNJ

Winthrop Partners - WNY, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Winthrop Partners - WNY, LLC reported holding 12,849 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$3.4M, representing 1.93% of its reported portfolio and ranking #22 among its reported holdings. Winthrop Partners - WNY, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)12.85K sh
Reported value held$3.40M
Portfolio Weight1.93%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Winthrop Partners - WNY, LLC's JNJ position evolved

Winthrop Partners - WNY, LLC first disclosed a stake in JNJ in Q4 2025 at 13,283 shares (US$2.7M). The position peaked in Q2 2026 at 13,875 shares, worth US$3.5M. Across 4 filings, Winthrop Partners - WNY, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 12,849 shares valued at US$3.4M — a reduction of -1,026 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 13.28K $2.75M New
Q1 2026 13.82K $3.38M Add
Q2 2026 13.88K $3.52M Hold
Q3 2026 12.85K $3.40M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Winthrop Partners - WNY, LLC held JNJ?

Winthrop Partners - WNY, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Winthrop Partners - WNY, LLC's current position in JNJ?

As of Q3 2026, Winthrop Partners - WNY, LLC holds 12.85K shares of JNJ (JOHNSON & JOHNSON), valued at $3.40M, representing 1.93% of its reported portfolio and ranking #22.

Has Winthrop Partners - WNY, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Winthrop Partners - WNY, LLC reduced its position in JNJ. The position peaked in Q2 2026 at 13.88K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.